Copper reduces infection risk by more than 40 percent

July 1, 2011
This is professor Bill Keevil of the University of Southampton. Credit: University of Southampton

Professor Bill Keevil, Head of the Microbiology Group and Director of the Environmental Healthcare Unit at the University of Southampton, has presented research into the mechanism by which copper exerts its antimicrobial effect on antibiotic-resistant organisms at the World Health Organization's first International Conference on Prevention and Infection Control (ICPIC).

'New Insights into the Antimicrobial Mechanisms of Copper Touch Surfaces' observes the survival of pathogens on conventional hospital touch surfaces contributes to increasing incidence and spread of antibiotic resistance and infections. Keevil proposes antimicrobial copper surfaces as one way to address this, since they achieve a rapid kill of significant bacterial, viral and .

He reported studies on dry surfaces with a range of pathogens, concluding that: "Copper's rapid destruction of pathogens could prevent mutational resistance developing and also help reduce the spread of to receptive and potentially more virulent organisms, as well as genes responsible for . Additionally, copper touch surfaces could have a key role in preventing the transmission of healthcare-associated infections. Extensive have demonstrated copper's antimicrobial efficacy against key organisms responsible for these infections, and around the world are now reporting on its efficacy in busy, real-world environments."

The latest trial – conducted in intensive care units at three facilities in the United States – has shown that the use of antimicrobial copper surfaces in intensive care unit rooms resulted in a 40.4% reduction in the risk of acquiring a hospital infection.

The study, funded by the US Department of Defense, was designed to determine the efficacy of antimicrobial copper in reducing the level of pathogens in hospital rooms, and whether such a reduction would translate into a lower rate of infection.

Researchers at the three hospitals involved in the trial – Memorial Sloan Kettering Cancer Center in New York, the Medical University of South Carolina (MUSC) and the Ralph H. Johnson VA Medical Center, both in Charleston, South Carolina – replaced commonly-touched items such as bed rails, overbed tray tables, nurse call buttons and IV poles with antimicrobial copper versions.

Data presented today by trial leader Dr Michael Schmidt, Professor and Vice Chairman of Microbiology and Immunology at MUSC, at ICPIC, demonstrated a 97% reduction in surface pathogens in rooms with copper surfaces, the same level achieved by "terminal" cleaning: the regimen conducted after each patient vacates a room.

Dr Schmidt said of the results: "Bacteria present on ICU room surfaces are probably responsible for 35-80% of patient infections, demonstrating how critical it is to keep hospitals clean. The copper objects used in the clinical trial supplemented cleaning protocols, lowered microbial levels, and resulted in a statistically significant reduction in the number of infections contracted by patients treated in those rooms."

Explore further: Study finds copper proves effective against new E. coli strains

Related Stories

Study finds copper proves effective against new E. coli strains

June 2, 2011
As the World Health Organisation suggests the E. coli outbreak in Germany is a strain never before seen in an outbreak – O104:H4 – laboratory science conducted at the University of Southampton indicates a role for ...

Recommended for you

Co-infection with two common gut pathogens worsens malnutrition in mice

July 27, 2017
Two gut pathogens commonly found in malnourished children combine to worsen malnutrition and impair growth in laboratory mice, according to new research published in PLOS Pathogens.

Finish your antibiotics course? Maybe not, experts say

July 27, 2017
British disease experts on Thursday suggested doing away with the "incorrect" advice to always finish a course of antibiotics, saying the approach was fuelling the spread of drug resistance.

Phase 3 trial confirms superiority of tocilizumab to steroids for giant cell arteritis

July 26, 2017
A phase 3 clinical trial has confirmed that regular treatment with tocilizumab, an inhibitor of interleukin-6, successfully reduced both symptoms of and the need for high-dose steroid treatment for giant cell arteritis, the ...

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

deatopmg
not rated yet Jul 01, 2011
Everything is going to turn green! That is why silver has been used for these applications instead of copper.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.